导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.20% | 574/1050 |
| 近一周 | -0.06% | 296/1104 |
| 近一月 | -8.41% | 1016/1103 |
| 近一季 | -23.83% | 1041/1092 |
| 近半年 | -0.57% | 467/1070 |
| 近一年 | 0.57% | 582/1018 |
| 近两年 | 101.39% | 199/926 |
| 近三年 | 60.91% | 208/834 |
| 成立以来 | 61.80% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.68% 937/1070 |
54.95% 199/1101 |
- - |
- - |
| 2025 | 57.47% 128/1065 |
5.96% 344/1014 |
5.91% 245/1038 |
45.12% 126/1050 |
-3.31% 622/1065 |
| 2024 | 3.10% 495/1011 |
-7.22% 660/960 |
-3.13% 512/983 |
7.05% 815/991 |
7.16% 90/1011 |
| 2023 | -18.05% 622/952 |
7.50% 197/880 |
4.37% 42/895 |
-19.66% 861/915 |
-9.09% 818/952 |
| 2022 | -17.85% 250/867 |
-22.73% 662/773 |
23.21% 5/806 |
-0.79% 21/845 |
-13.03% 822/867 |
| 2021 | 23.56% 129/740 |
-16.14% 547/580 |
22.95% 118/659 |
22.54% 11/704 |
-2.20% 520/740 |
| 2020 | 19.75% 383/554 |
-11.64% 392/419 |
20.03% 286/466 |
-5.14% 462/517 |
19.02% 133/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 海富通先进制造股票A VS. 东吴新产业精选股票A(580008) |